AppLovin CEO & Chairperson Awarded RSU Grant
AppLovin Corp
Subscribe to track APP
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
AppLovin CEO & Chairperson Awarded RSU Grant
Company: AppLovin Corp (APP) Form: 4 | Filed: 2025-10-31 Significance: Low
Insider: Foroughi Arash Adam Title: CEO & Chairperson | Relationship: Director, Officer, Ten Percent Owner
Transaction: • Type: Grant (RSUs) • Shares: 20,236 • Price: $0.00 • Value: $0 • Owned After (Direct): 2,610,290
Key Insight: This is a routine Restricted Stock Unit (RSU) grant as part of executive compensation. The shares have a vesting schedule, aligning the CEO's interests with long-term shareholder value.
Market Context: The grant represents a negligible 0.007% of shares outstanding, resulting in minimal dilution. It is not a market transaction and has no immediate price impact.
Comprehensive Analysis
SEC Filing Analysis: AppLovin Corp (APP)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The CEO and Chairperson of AppLovin, Arash Adam Foroughi, received a routine grant of 20,236 Restricted Stock Units (RSUs) as part of his compensation package.
- Market Impact: The impact is neutral. This is a non-market transaction with a value of $0, representing a standard form of equity compensation for a key executive.
Company Information
| Field | Value |
|---|---|
| Company | AppLovin Corp |
| Ticker Symbol | APP |
| CIK | 0001751008 |
| Industry | SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. |
Insider Information
| Field | Value |
|---|---|
| Name | Foroughi Arash Adam |
| CIK | 0001848395 |
| Title/Position | CEO & Chairperson |
| Relationship | Director, Officer, Ten Percent Owner |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-30 |
| Transaction Code | A (Grant) |
| Security Type | Class A Common Stock (as RSUs) |
| Shares Involved | 20,236 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After (Direct) | 2,610,290 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.00% |
| Shares Transacted | 20,236 |
| % of Shares Outstanding | 0.007% |
| Post-Transaction Ownership (Direct) | 2,610,290 shares (0.85% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with a market capitalization of $212.02 billion, this grant is financially immaterial. The transaction value is $0, and the potential future value is a standard cost of executive compensation.
- Ownership Concentration: The insider holds a significant position in the company. Following this grant, his direct holdings represent approximately 0.85% of shares outstanding. Including indirect holdings in trusts, his total beneficial ownership is substantially higher, solidifying his status as a major stakeholder.
- Dilution Impact: The issuance of 20,236 shares as RSUs represents a potential dilution of only 0.007% of the total shares outstanding. This is a negligible impact on existing shareholders and is a common practice for retaining and incentivizing top executives.
- Transaction Significance: The transaction's significance is low due to its nature as a non-market compensation grant and its minuscule size relative to the company's market cap and share base. It does not signal new information about the company's near-term prospects.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants to executives are expected and priced into compensation models. This transaction does not involve open market activity and therefore provides no new signal to investors regarding the stock's valuation.
Volume & Sentiment
- Expected Volume Impact: None. This was not an open-market transaction.
- Sentiment Indicator: Neutral. This filing is informational and confirms the alignment of executive and shareholder interests through a long-term vesting schedule.
Investment Insights
Positive Market Indicators
- Executive Alignment: The grant, with its multi-year vesting schedule, aligns the CEO's financial interests with the long-term performance of the company's stock.
Risk Factors
- Routine Dilution: While this specific grant is minor, investors should monitor the cumulative effect of all equity compensation plans on shareholder dilution over time.
Key Takeaways
- The transaction is a standard RSU grant to the CEO, not an open-market purchase or sale.
- The financial impact on the company and the dilutive effect on shareholders are negligible.
- The grant reinforces the long-term incentive structure for a key executive who is also a co-founder and major shareholder.
Additional Context
Transaction Notes
- Vesting Schedule: The RSUs are subject to a vesting schedule, with the first 25% vesting on February 20, 2026, and the remainder vesting quarterly thereafter. This ensures the executive must remain with the company to realize the full value of the grant.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
